Stay Curious. Stay Connected.
MailNewsletters♡Donate Now
Sign up
*Password must be at least 8 characters and contain one uppercase letter, one lowercase letter, one number and one symbol.
Already have an account?
By submitting, you consent that you are at least 18 years of age and to receive information about MPR's or APMG entities' programs and offerings. The personally identifying information you provide will not be sold, shared, or used for purposes other than to communicate with you about MPR, APMG entities, and its sponsors. You may opt-out at any time clicking the unsubscribe link at the bottom of any email communication. View our Privacy Policy.
Sign in to your profile
Forgot Password?
New to MPR News?
Welcome back
to news
for you
Reset Password

Enter the username on file and we'll send you a code to reset your password.

Still require assistance or not sure what your User Name is?
Welcome back
to news
for you
Email Verification

A verification code has been emailed to

Still awaiting the code?
MPR News Staff
St. Paul

Report: Medical marijuana aiding most Minnesota patients

Wyatt Hauser's medical marijuana.
The two kinds of medical marijuana tinctures a young patient takes sit with his lunch of bananas, ham and applesauce.
Evan Frost | MPR News 2016

Go Deeper.

Create an account or log in to save stories.

Like this?

Thanks for liking this story! We have added it to a list of your favorite stories.

Most Minnesotans who took part in the launch year of the state's medical marijuana program reported "substantial benefits" from treatment, including minimal side effects and no serious consequences, the state Health Department said Tuesday.

Asked to rate the benefits of medical cannabis in their treatment on a scale of 1 (no benefit) to 7 (great deal of benefit), 64 percent of patients gave the therapy a 6 or 7. "Across all patients, In the area of symptom reduction, patients achieved at least a 30 percent reduction in symptoms (an amount considered clinically meaningful) for conditions including seizures, Tourette syndrome, Crohn's disease and muscle spasms," the agency said in a statement.

A "small but important" proportion of patients, 9 percent, indicated little or no benefit with a rating of 1, 2 or 3, the department said, adding that patients also reported that affordability continues to be a problem as medical cannabis is not covered by health insurance.

The study drew on data from survey results as well as enrollment, purchasing and related health information to describe the experience of patients using medical cannabis from the program's start on July 1, 2015, through June 30, 2016, the department added.

A complete study is scheduled to be released this summer.